Bay Street News, March 18th, 2024

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq: CAUD), a leading innovator of audience-based performance advertising […]

SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage […]

OLD GREENWICH, Conn., March 18, 2024 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP), (“Star Equity” or the […]

DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) — UpHealth, Inc. (“we,” “our,” “UpHealth,” or the “Company”) (NYSE: UPHL) today […]

GERMANTOWN, Md., March 18, 2024 (GLOBE NEWSWIRE) — Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralizing […]

AUSTIN, Texas, March 18, 2024 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW) will hold its Annual Meeting of Stockholders on […]

SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of […]

PETAH TIKVA, Israel, March 18, 2024 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative […]

TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) PKP2 Gene […]

TORONTO, March 18, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (TSXV: ART) (OTCQB: ARHTF), a global leader in the development […]